Novartis AG
NOVN
Company Profile
Business description
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Contact
Lichtstrasse 35
Basel4056
CHET: +41 613241111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
75,883
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,175.10 | 49.90 | 0.61% |
| CAC 40 | 7,532.96 | 30.18 | 0.40% |
| DAX 40 | 22,098.15 | 33.64 | 0.15% |
| Dow JONES (US) | 40,093.40 | 486.83 | 1.23% |
| FTSE 100 | 8,405.10 | 2.34 | -0.03% |
| HKSE | 21,976.84 | 67.08 | 0.31% |
| NASDAQ | 17,166.04 | 457.99 | 2.74% |
| Nikkei 225 | 35,705.74 | 666.59 | 1.90% |
| NZX 50 Index | 12,017.84 | 61.37 | 0.51% |
| S&P 500 | 5,484.77 | 108.91 | 2.03% |
| S&P/ASX 200 | 7,968.20 | 47.70 | 0.60% |
| SSE Composite Index | 3,295.06 | 2.23 | -0.07% |